85 related articles for article (PubMed ID: 9494531)
1. Interaction of swainsonine with lymphoid and highly perfused tissues: a pharmacokinetics explanation for sustained immunomodulation.
Bowen D; Southerland WM; Bowen CD; Hughes DE
Anticancer Res; 1997; 17(6D):4345-6. PubMed ID: 9494531
[TBL] [Abstract][Full Text] [Related]
2. A preliminary pharmacokinetic evaluation of the antimetastatic immunomodulator swainsonine: clinical and toxic implications.
Bowen D; Adir J; White SL; Bowen CD; Matsumoto K; Olden K
Anticancer Res; 1993; 13(4):841-4. PubMed ID: 8352552
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition effect of Swainsonine on the growth and metastasis of gastric cancer in vivo].
Liu B; Lin Y; Yin H
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):168-70. PubMed ID: 10920997
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
[TBL] [Abstract][Full Text] [Related]
5. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Oct; 3(10-11):1537-47. PubMed ID: 12946451
[TBL] [Abstract][Full Text] [Related]
6. [The role of cyclic nucleotides in the development of resistance to metastases after treatment with immunomodulators].
Veksler IG; Antonenko SG; Okolot EN; Chubinskaia SG
Eksp Onkol; 1984; 6(3):52-5. PubMed ID: 6094145
[TBL] [Abstract][Full Text] [Related]
7. Swainsonine: a new antineoplastic immunomodulator.
Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K
J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720
[TBL] [Abstract][Full Text] [Related]
8. [Incorporation of tritium into the DNA of hematopoietic tissues during prolonged administration of tritium oxide].
Mushkacheva GS; Kreslov VV
Radiobiologiia; 1983; 23(4):558-62. PubMed ID: 6611889
[TBL] [Abstract][Full Text] [Related]
9. The effect of toxicokinetics on murine mercury-induced autoimmunity.
Hultman P; Nielsen JB
Environ Res; 1998 May; 77(2):141-8. PubMed ID: 9600807
[TBL] [Abstract][Full Text] [Related]
10. Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible mice.
Havarinasab S; Björn E; Nielsen JB; Hultman P
Toxicol Appl Pharmacol; 2007 May; 221(1):21-8. PubMed ID: 17399758
[TBL] [Abstract][Full Text] [Related]
11. Effect of subacute swainsonine (locoweed; Oxytropis sericea) consumption on immunocompetence and serum constituents of sheep in a nutrient-restricted state.
Taylor JB; Strickland J; May T; Hawkins DE
Vet Hum Toxicol; 2000 Aug; 42(4):199-204. PubMed ID: 10928681
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulatory effects of Ipomoea carnea in rats vary depending on life stage.
Hueza IM; Górniak SL
Hum Exp Toxicol; 2011 Oct; 30(10):1690-700. PubMed ID: 22021224
[TBL] [Abstract][Full Text] [Related]
13. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: immunomodulatory properties.
White SL; Schweitzer K; Humphries MJ; Olden K
Biochem Biophys Res Commun; 1988 Jan; 150(2):615-25. PubMed ID: 3124836
[TBL] [Abstract][Full Text] [Related]
15. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
17. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.
Goss PE; Reid CL; Bailey D; Dennis JW
Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity studies of Ethylene Glycol Ethers: 2-Methoxyethanol, 2-Ethoxyethanol, 2-Butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76-2) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
Dieter M
Toxic Rep Ser; 1993 Jul; 26():1-G15. PubMed ID: 12209180
[TBL] [Abstract][Full Text] [Related]
19. [A review of the study on swainsonine--toxic elements of locoweed].
Shi Y; Li M; Xu F
Zhong Yao Cai; 1999 Jan; 22(1):47-9. PubMed ID: 12892056
[No Abstract] [Full Text] [Related]
20. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
